Recent Updates
Recently added Catalysts
GKOS Positive Sentiment

Glaukos Announces Participation in Upcoming Investor Conferences

Tuesday, November 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Glaukos Corporation announced that its management team will participate in two upcoming investor conferences. The company will present at the Stifel Healthcare Conference on November 10, 2026, in New York City. Additionally, Glaukos is scheduled to speak at the Jefferies Global Healthcare Conference. These events provide opportunities for the company to engage with the investment community regarding its ophthalmic therapies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Glaukos is actively engaging with investors.
  • Participation in notable healthcare conferences.
  • Focus on innovative therapies for eye conditions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+66%
120-day peak, hindsight
Typical move
8.7%
average across 4 past catalysts
Lead asset
Lufepirsen
Phase 2 · Persistent Corneal Epithelial Defect

Full Press Release Details

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences:Stifel Healthcare Conference on Tuesday, November 10, 2026, at 8:40 a.m. ET in New York City, NYJefferies Global Healthcare Conference on Wednesday, November

Frequently Asked Questions

Which conferences will Glaukos participate in?

Glaukos will attend the Stifel Healthcare Conference and Jefferies Global Healthcare Conference.

When is the Stifel Healthcare Conference?

The Stifel Healthcare Conference is scheduled for November 10, 2026.

What is Glaukos focused on?

Glaukos focuses on novel therapies for glaucoma and other eye conditions.

Where will the conferences take place?

The conferences will be held in New York City, NY.

ShareAdd on Google
Tags: GKOS Glaukos investor conferences Stifel Healthcare Jefferies Global Healthcare ophthalmic therapies
Last updated: Nov 3, 2026

Biotech snapshot

Cash runway
$337M liquidity · $0M/mo burn
Low dilution risk
Lead asset
LufepirsenPhase 2
Persistent Corneal Epithelial Defect →

Catalyst track record

+66%
best trade around GKOS's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for GKOS.

See every catalyst's timing & PoA →